TXA is effective and safe for reducing blood loss and transfusion in TKA patients
TXA is effective and safe for reducing blood loss and transfusion in TKA patients
Is tranexamic acid clinically effective and safe to prevent blood loss in total knee arthroplasty? A meta-analysis of 34 randomized controlled trials
Eur J Orthop Surg Traumatol. 2015 Apr;25(3):525-41Did you know you're eligible to earn 0.5 CME credits for reading this report? Click Here
Synopsis
34 randomized controlled trials (2,594 patients) were used in this meta-analysis analyzing the safety and efficacy of tranexamic acid (TXA) in patients undergoing primary total knee arthroplasty (TKA). Pooled results demonstrated intravenous (IV) and intraarticular (IA) use of TXA significantly reduced total blood loss, postoperative blood loss, hemoglobin (Hb) loss, and blood transfusion without ...
To view the full content, login to your account,
or start your 30-day FREE Trial today.
FREE TRIAL
LOGIN
Forgot Password?
Explore some of our unlocked ACE Reports below!
Learn about our AI Driven
High Impact Search Feature
Our AI driven High Impact metric calculates the impact an article will have by considering both the publishing journal and the content of the article itself. Built using the latest advances in natural language processing, OE High Impact predicts an article’s future number of citations better than impact factor alone.
Continue
Join the Conversation
Please Login or Join to leave comments.